The triple combination indinavir-zidovudine-lamivudine is highly synergistic. - Wikidata - wikimedia - TriplyDB

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

http://www.wikidata.org/entity/Q33979237

about

Gag-Pol processing during HIV-1 virion maturation: a systems biology approach Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia.Kinetics of the viral cycle influence pharmacodynamics of antiretroviral therapy.Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii.A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.

P2860

Q28533696-1863EF92-D546-40BD-8117-789FBE8C0005 Q37339294-1D680DD4-A002-48C8-BEAE-5A76B2AA13F2 Q38502298-C6EDBA57-3D61-4DA6-80E1-7112A1468774 Q38848973-B73F9022-1736-438A-A5E7-F270808CCFF7 Q39755479-4448123A-ADD7-4FD2-8E72-323EE42177DE Q41338910-B58C30EF-B217-4B09-AC8A-0C9E1BF56B13 Q41996871-E481C278-9C43-4890-B62A-5485EB3B58C5

P2860

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

http://www.wikidata.org/entity/Q33979237

description

2000 nî lūn-bûn

@nan

2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

@ast

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

@en

type

label

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

@ast

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

@en

prefLabel

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

@ast

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

@en

P1433

Q33979237-A94E8FCB-AC00-4C0C-A71B-D43C98A15C26

P1476

Q33979237-1F348FFB-3215-4C0B-B3EC-FFF47383DD13

P2093

Q33979237-0375389C-C715-4A25-B6B0-A915DFF7B3A0

Q33979237-69CE3CAC-F9E3-45C5-B970-F22EA949FD49

Q33979237-8FE6954D-DE26-49A0-89CF-ECA7F0B379AE

Q33979237-D3369855-A826-43CF-9AAC-9DA055428015

Q33979237-EDD99AA2-B2AE-476F-A9A0-250C244BAC8C

P2860

Q33979237-24437733-EEDD-4053-BCC2-83311397431E

Q33979237-25075FF2-DF5D-4277-8136-DD38DF207EA0

Q33979237-708A236E-0C2F-4259-9B4B-CCB6E33CFAB8

Q33979237-868D2F4F-3D86-40A5-A009-AA4CAE943299

Q33979237-9D373094-040E-479E-8F68-EB568DB49056

Q33979237-A45F2480-5771-496B-A36C-44B8DB39A8F2

Q33979237-B4468762-F11B-4F09-A16C-17082C32D927

Q33979237-D2332A75-9E8C-4A6E-8200-601D11758B1E

P304

Q33979237-4DBBB905-A6F6-4595-87D6-9B2BBA05BCF5

P31

Q33979237-85A1EE0F-802F-429A-8340-6C2C5D146CBF

P356

Q33979237-98CBE339-82DC-4FDB-8464-A4E7D3055D3D

P407

Q33979237-709544A3-4189-4D2E-A014-F87F5BE9307B

P433

Q33979237-8DA0F5E4-350B-430D-B72F-997279F02F9A

P478

Q33979237-205E2ABF-6F0F-4C58-B6E0-DF1C4A4A37F3

P577

Q33979237-9C78CF83-041F-4379-87D5-5673BA608EEF

P5875

Q33979237-07D7A543-4EA4-4B86-9F63-F555E0AB6BB9

P698

Q33979237-9424F602-B669-4AC3-A189-396D18FB657E

P932

Q33979237-61DF869D-6343-40C5-9160-DAB8B9AD62B0

P356

AAC.44.4.1051-1058.2000

P1433

Antimicrobial Agents and Chemotherapy

P1476

The triple combination indinavir-zidovudine-lamivudine is highly synergistic.

@en

P2093

D Z D'Argenio

http://www.w3.org/2001/XMLSchema#string

G L Drusano

http://www.w3.org/2001/XMLSchema#string

J A Bilello

http://www.w3.org/2001/XMLSchema#string

O Weislow

http://www.w3.org/2001/XMLSchema#string

S Snyder

http://www.w3.org/2001/XMLSchema#string

P2860

A three-dimensional model to analyze drug-drug interactions.

The search for synergy: a critical review from a response surface perspective.

Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine.

Do dual nucleoside regimens have a role in an era of plasma viral load-driven antiretroviral therapy?

Quantitative infectivity assay for HIV-1 and-2.

New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity.

Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.

Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables.

P304

1051-1058

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.44.4.1051-1058.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24491921

http://www.w3.org/2001/XMLSchema#string

P698

10722511

http://www.w3.org/2001/XMLSchema#string

P932

89812

http://www.w3.org/2001/XMLSchema#string